H.E.A.L. Marketplace sold four herbal products as unapproved new drugs with disease-treatment claims, FDA says.
What happened
In March 2023, FDA reviewed www.healmarketplace.com and www.ladyofherbs.com, which redirect or link to www.healmarketplace.shop, and found the company takes orders there for four products. The websites claimed the products treat diseases such as epilepsy, colds, flu, high blood pressure, and insomnia. FDA determined the products are unapproved new drugs and are misbranded because they lack adequate directions for use.
What FDA found
The website claims make the products drugs intended to cure, mitigate, treat, or prevent disease.
section 201(g)(1)(B) of the Act [21 U.S.C. § 321(g)(1)(B)]The products are new drugs because they are not generally recognized as safe and effective for their claimed uses and lack FDA approval.
sections 201(p), 301(d), and 505(a) of the Act [21 U.S.C. §§ 321(p), 331(d), 355(a)]The products are misbranded because they fail to bear adequate directions for use by a layperson.
section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)]; 21 CFR 201.5Introducing or delivering the misbranded drugs into interstate commerce violates the Act.
section 301(a) of the Act [21 U.S.C. § 331(a)]
What FDA wants
FDA asks the company to notify it in writing within 15 working days of receipt of the letter of the specific steps taken to address the violations and prevent recurrence, with supporting documentation. If corrective actions cannot be completed in that time, the company must state the reason and the time within which it will do so.
Who should pay attention
- online sellers of herbal tinctures and tonics
- companies making disease-treatment claims on product websites
- brands and retailers offering supplements with drug-like claims
This is a summary. Read the original letter on fda.gov.